Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Ductal Carcinoma In Situ
Interventions: DRUG: Herceptin (Trastuzumab)
Sponsor: M.D. Anderson Cancer Center